Ellen Warner

Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

Ellen Warner · JAMA · 2004 · 1.2K citations

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Contralateral Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Kelly Metcalfe, Henry T. Lynch, Parviz Ghadirian et al. · Journal of Clinical Oncology · 2004 · 616 citations

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

Antonis C. Antoniou, Alex Cunningham, Julian Peto et al. · British Journal of Cancer · 2008 · 529 citations · Full text

Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer

Ellen Warner, Donald B. Plewes, Rene Shumak et al. · Journal of Clinical Oncology · 2001 · 460 citations